Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DecisionView, Inc.
DecisionView Board of Directors Appoints James P. Scullion as CEO and President
April 19th, 2009
DecisionView, Inc., the leading provider of Clinical Optimization Solutions for the Life Sciences industry, announced that its Board of Directors has appointed James P. Scullion to the role of Chairman, President and CEO of DecisionView, effective immediately. Most recently, he held the role of Chairman for DecisionView. Scullion succeeds Steve Andrade as the Company's President and Chief Executive Officer. "I'm very pleased that Jim has agreed to join DecisionView as its new CEO," said Chris Hollenbeck, a DecisionView Board Member. "We believe the market for clinical optimization solutions is poised for significant growth. Jim has over two decades of experience leading...
Source: Pharma Investments, Ventures & Law Weekly (2009-04-19)
|
